Side effects are mostly gastrointestinal and transient, consistent with the drug class
These efforts will not only help optimize the use of semaglutide in diverse patient populations but also advance our understanding of the intricate relationships between metabolic health and hormonal regulation
Lifestyle modifications such as avoiding wearying activities, nutritional adjustments, physiotherapy, and occupational therapy
With incretin-based drugs, much of the reported lean mass loss may not be skeletal muscle, but some is
Phase 3 Clinical Trials Retatrutide is currently being evaluated in a series of Phase 3 clinical trials known as the TRIUMPH program
A lot of people have stomach problems like nausea, vomiting, and diarrhea